Pharmaceutical & API manufacturing sites in Netherlands

50 drug establishments in Netherlands are registered with the US FDA; 23 (46%) list API manufacture among their operations. 38 registrant companies are identified, 1 of them with more than one API site here; sites whose registrant is not resolved to a company profile are not counted. 39 published sites are matched to an EU or UK GMP certificate inspected within the last three years.

Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology

FDA-registered sites
50
Registered for API manufacture
23
Identified registrants
38
Current EU/UK GMP match
39

Registered operations

Analytical testing26
API manufacture23
Drug manufacture19
Labelling16
Packaging15
Sterilisation6
Repackaging4
Relabelling3

A site can register several operations, so these do not add up to the site total.

Companies headquartered in Netherlands

API manufacturing sites (23)

Other sites with EU/UK GMP documents (21)

Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.